comparemela.com

Latest Breaking News On - Board member of the company - Page 1 : comparemela.com

Sequans Communications S A : 1 Approval of the statutory financial statements for the year ended December 31, 2023 2 Approval of the consolidated financial statements for the year ended December 31, 2023 3 Allocation of net loss for the year ended December 31, 2023 4 Related-party agreements 5 Approval of the compensation plan for non-executive directors 6 Renewal of Mr Georges Karam as director 7 Renewal of Mr Wes Cummins as director 8 Renewal of Mr Zvi Slonimsky as director - Form 6-K

Sequans Communications S A : 1 Approval of the statutory financial statements for the year ended December 31, 2023 2 Approval of the consolidated financial statements for the year ended December 31, 2023 3 Allocation of net loss for the year ended December 31, 2023 4 Related-party agreements 5 Approval of the compensation plan for non-executive directors 6 Renewal of Mr Georges Karam as director 7 Renewal of Mr Wes Cummins as director 8 Renewal of Mr Zvi Slonimsky as director - Form 6-K
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Petrobras : informs about decision in popular action lawsuit - Form 6-K -April 08, 2024 at 08:04 am EDT

Resignation of Company Board Member

Panevezio statybos trestas AB informs that the Board Member Gvidas Drobuzas resigned as a Board Member of the Company. After resignation of the Board Member, a new Board Member of the Company will.

Therapeutic Solutions International Launches Adult Stem Cell Therapy Company Focused on Curing Epilepsy

16.01.2024 - Therapeutic Solutions International, Inc. (TSOI) announced the formation of Epilepsy Bio, Inc., a subsidiary company dedicated to commercializing intellectual property, clinical, and mechanistic findings associated with cellular and immunological .

Therapeutic Solutions International Reports Landmark Advancement in Stem Cell Therapy of Frontotemporal Dementia

ELK CITY, Idaho, September 11, 2023 Therapeutic Solutions International, Inc. (TSOI), announced today the development of a new therapeutic approach for treatment of Frontotemporal Dementia, by combining the activation of endogenous anti-inflammatory cells in the nervous system, together with regenerative cell intervention in the form of stem cell therapy, and molecules capable of activating endogenous stem cells already present in the patient.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.